header logo image

Policy, legal and ethical issues in … – Issues in Genetics

May 20th, 2015 6:47 pm

Feature Learn more about human subjects research

The use of human subjects in the field of genomics raises a number of key policy considerations that are being addressed at NHGRI and elsewhere. Learn more about his important topic with a new fact sheet from the Policy and Program Analysis Branch. Read more

Informed consent is the basic and primary tool through which investigators communicate with each potential study participant and is vital to ensuring that the research purpose, any risks and possible benefits, or other implications of participation are understood. NHGRI's online Informed Consent Resource has helped thousands of researchers navigate the informed consent process since 2009. Now, the ICR has been updated to keep pace with advances in genomics over the past several years. Read more

NIH has issued a position statement on the use of public or private cloud systems for storing and analyzing controlled-access genomic data under the NIH Genomic Data Sharing (GDS) Policy. Read the Position Statement

The U.S. Food and Drug Administration (FDA) today announced steps it will take to ensure that certain tests used by health care professionals to diagnose and treat patients provide accurate, consistent and reliable results to inform patient care. These steps come at a critical time for genomic, or precision, medicine. As more and more genetic tests are developed and marketed, the public must be able to rely on the accuracy and clinical validity of these tests. Read the FDA Release Read a statement from NIH Director Francis Collins

Last Updated: May 8, 2015

Read more:
Policy, legal and ethical issues in ... - Issues in Genetics

Related Post

Comments are closed.


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick